Dentons advises Enodia Therapeutics on a €20.7 million seed financing

Enodia Therapeutics, a biotechnology business established in France, received advice from Dentons about its €20.7 million seed fundraising round. The funds will be utilized to expedite the rollout of its technological platform and accomplish significant new development milestones.